Clinical Trial Update: Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the diagnostic performance of the C-Tb skin test compared with QuantiFERON-TB, with a safety comparison of C-Tb against Tuberculin PPD R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• C-Tb
• QuantiFERON-TB Gold (Interferon-gamma release assay (IGRA) for latent TB)
• Tuberculin PPD RT23 (Purified Protein Derivative)

Snippet

Sponsor: Statens Serum Institut | Conditions: Tuberculosis | Phase 3 | Status: COMPLETED